down arrow

Concord Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE858L01010
  • NSEID:
  • BSEID: 538965
INR
77.80
0.5 (0.65%)
BSENSE

Dec 05

BSE+NSE Vol: 203

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Concord Drugs Ltd stock-summary
stock-summary
Concord Drugs Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved.
Company Coordinates stock-summary
Company Details
Survey No 249 Brahmanapally V, Hayathnagar M Ranga Reddy Telangana : 501511
stock-summary
Tel: 91-40-24036379
stock-summary
http://www.concorddrugs.in
stock-summary
concorddrugsltd@gmail.com
Registrar Details
Aarthi Consultants Pvt Ltd, 1-2-285 , Domalaguda, Hyderabad
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 10.00 Cr
Number of Shares
1 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
27-Oct-2023
1
10.00
342266
10
Conversion of Warrants
12-Oct-2023
96.58
9.66
342264
10
Conversion of Warrants
28-Mar-2023
93.15
9.32
285860
10
Conversion of Warrants
27-Mar-2023
90.3
9.03
285860
10
Conversion of Warrants
30-Jun-2019
87.44
8.74
882000
10
As Per Shareholding Pattern
30-Jun-2019
87.44
8.74
882000
10
As Per Shareholding Pattern
14-May-2019
87.44
8.74
882000
10
Conversion of Warrants
15-Nov-2017
78.62
7.86
618000
10
Allotment of Equity To Others
05-Apr-2011
72.44
7.24
1633750
10
Allotment of Equity To Others
05-Apr-2011
72.44
7.24
1633750
10
Allotment of Equity To Others
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Nagi Reddy Seelam (28.61%)

Highest Public shareholder

Ganga Devi Loya (2.13%)

Individual Investors Holdings

44.95%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
S Nagi Reddy
Chairman & Managing Director
42.5 lacs
K Ramchandra Reddy
Independent Director
0
Koni Reddy
Whole Time Director & CFO
19.0 lacs
S. Nagavenkata Hareesh
Independent Director
0
S. Manoj Kumar Reddy
Whole-time Director
19.0 lacs
Summela Kasu
Independent Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Cost of Material Consumed
28.2246
0%
 
100
Cost of Material Consumed
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceuticals Goods
51.80
100.00%
 
100
Pharmaceuticals Goods
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
10 Cr
(Quarterly Results - Sep 2025)
Net Profit:
0 Cr
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 75 Cr (Micro Cap)

stock-summary
P/E

134.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.49

stock-summary
Return on Equity

1.69%

stock-summary
Price to Book

2.25

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."